Physician profile
Thomas A Stout
NPI 1336144294
$6,414.23
in general payments reported to CMS, 2019-2025
18 companies · $429 in 2025
The $429 reported for 2025 was more than what a typical Corneal and Contact Management provider received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,648 · 2020: $186 · 2021: $368 · 2022: $401 · 2023: $324 · 2024: $57.61 · 2025: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $811.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $4,437.83 | 2019-2021 | |
| Coopervision INC. | $1,035.00 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Bausch & Lomb Americas INC. | $206.30 | 2022-2025 | Infuse, Biotrue One Day |
| Novartis Pharmaceuticals Corporation | $134.01 | 2019-2022 | |
| Abb Con-Cise Optical Group LLC | $114.66 | 2019 | |
| Allergan, INC. | $102.88 | 2021-2022 | |
| Maculogix, INC. | $57.24 | 2019-2020 | |
| Alcon Vision LLC | $49.93 | 2023-2025 | Tryptyr, Total30 |
| Optovue, INC. | $45.15 | 2019 | |
| Carl Zeiss Meditec, INC. | $44.49 | 2019 | |
| Oyster Point Pharma, INC. | $36.91 | 2022-2025 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $31.15 | 2020-2022 | |
| Abbvie INC. | $27.85 | 2022 | |
| Biotissue Holdings INC. | $21.05 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $20.31 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Lkc Technologies, INC. | $16.41 | 2025 | |
| Spark Therapeutics, INC. | $13.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Stout listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.